Written by Klarity Editorial Team
Published: May 7, 2026

If you’re a psychiatrist or psychiatric nurse practitioner considering telehealth work, you’ve probably wondered: Can I prescribe anxiety medications remotely? What about controlled substances like benzodiazepines? Do the rules differ by state?
The short answer: Yes, you can prescribe anxiety medications via telehealth — including controlled substances — but the details depend on your credentials, your state’s laws, and federal telehealth regulations that continue to evolve.
Here’s what you need to know about prescribing authority for anxiety treatment in 2026, with real regulatory guidance and practical insights for building your telehealth practice.
Let’s start with the big picture: federal law.
Historically, the Ryan Haight Act required at least one in-person visit before prescribing controlled substances (Schedule II-V drugs, including benzodiazepines for anxiety). That changed during COVID-19, when the DEA suspended this requirement to expand access to care.
Good news for 2026: Those telehealth flexibilities have been extended through December 31, 2026. This means you can currently prescribe controlled anxiety medications — alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan) — via telehealth without ever seeing the patient in person.
Over 7 million controlled substance prescriptions were written via telemedicine in 2024 alone under these rules. The extension gives the DEA and HHS time to craft permanent regulations (expected late 2026) that will likely include a special telemedicine prescribing registration.
What this means for your practice:
Reality check: While federal law allows telehealth prescribing broadly, you still must comply with state-specific rules — and that’s where things get more nuanced.
Most states align with federal allowances, but some add extra conditions. Here’s what matters in the states with the largest telehealth markets:
Florida explicitly permits teleprescribing of Schedule II drugs for psychiatric disorders — meaning you can manage severe anxiety or comorbid ADHD remotely. Benzodiazepines (Schedule IV) have no telehealth restrictions.
Key requirement: You must check Florida’s PDMP (E-FORCSE) before prescribing any controlled substance.
Gotcha: Out-of-state providers with only a Florida telehealth registration (not a full FL license) cannot prescribe controlled substances remotely. You need full Florida licensure to prescribe anxiolytics via telehealth.
Texas allows telehealth prescribing for psychiatric conditions, including anxiety, but prohibits telemedicine treatment of chronic pain with controlled drugs. Anxiety treatment isn’t classified as chronic pain management, so you’re clear to prescribe benzodiazepines remotely.
Key requirement: Establish a valid patient-practitioner relationship via live audio-visual exam. Check the Texas PMP (Prescription Monitoring Program) before prescribing.
No special quantity limits for physicians prescribing controlled substances via telehealth (those apply to teledentistry, not general telemedicine).
California imposes no unique restrictions beyond federal law. You can prescribe anxiety medications (including controlled substances) via telehealth as long as you conduct an appropriate evaluation.
Payment parity: AB 744 requires private insurers to pay telehealth visits at the same rate as in-person — a win for your bottom line.
New York integrates telehealth into standard practice with no special prescribing limits for controlled substances.
Strict PDMP requirement: You must check New York’s iSTOP database for every controlled substance prescription, including benzodiazepines — no exceptions.
Medicare note: Federal rules may require an in-person visit within 6 months for Medicare tele-mental health (enforcement delayed through 2024-2025; verify current policy).
Neither state restricts telehealth prescribing for mental health beyond federal requirements. Both mandate PDMP checks for controlled substances (PA’s ABC-MAP and Illinois’ PMP).
Illinois bonus: Strong telehealth parity law (2021) ensures insurers cover tele-mental health equivalently to in-person.
Here’s where credentials matter significantly.
You have unrestricted authority to prescribe any anxiety medication in all 50 states — SSRIs, SNRIs, benzodiazepines, beta-blockers, everything. No supervision required, no collaboration agreements, no quantity limits (beyond standard medical practice).
Your telehealth prescribing powers are essentially equivalent to in-person care.
Your authority depends entirely on your state’s scope of practice laws.
Full Practice Authority States (e.g., New York, Oregon, Washington, Arizona):You can evaluate, diagnose, and prescribe anxiety medications — including controlled substances — completely independently. Your authority matches a psychiatrist’s.
Example: New York enacted full practice for NPs in 2022, removing all collaboration requirements. A PMHNP in NY can now open their own practice managing anxiety without any physician oversight.
Reduced/Restricted Practice States (e.g., Texas, Florida, Pennsylvania, California*):
You need a collaborative agreement or supervision with a physician to prescribe.
Texas:
Florida:
Pennsylvania:
California* (transitioning):
Illinois (reduced-to-full pathway):
Benzodiazepines (Schedule IV): In states requiring collaboration, your supervising physician must explicitly authorize benzodiazepine prescribing in your agreement. You’ll need your own DEA registration.
Schedule II stimulants (sometimes used off-label for anxiety or comorbid ADHD): More restricted for NPs in many states. Texas and Florida essentially prohibit outpatient NP prescribing of Schedule II; other states require enhanced physician oversight.
These requirements aren’t just bureaucratic — they affect your practice economics:
Compare this to psychiatrists: No collaboration fees, no geographic restrictions, no supervision burden.
Understanding reimbursement helps you evaluate telehealth opportunities realistically.
Initial evaluation (90792): Psychiatric diagnostic evaluation with medication management
15-minute med check (99213): Routine follow-up for established patient
25-minute moderate-complexity visit (99214):
With brief therapy (add code 90833 for 30-min therapy):
Here’s a key difference: Medicare reimburses NPs at 85% of the physician fee schedule when billing under their own NPI.
Example: A 99213 visit pays a psychiatrist ~$95, but an NP ~$81 for the same service.
Private insurers often follow Medicare’s lead (though some pay NPs at parity). Many Medicaid programs pay NPs the same as physicians.
‘Incident to’ billing (where an NP’s service bills under a supervising physician’s NPI at 100% rate) is generally not feasible in psychiatry or telehealth.
What this means for platforms: Some may assign more patients to psychiatrists due to higher per-visit revenue, or they may account for the rate difference when setting provider compensation.
Good news: Most states now require insurers to pay telehealth visits at the same rate as in-person:
Medicare: Temporary telehealth parity extended through at least late 2024/early 2025, likely into 2026. Psychiatrists can bill Medicare for telemedicine anxiety follow-ups as they would in-person.
Texas caveat: No state-mandated payment parity for private insurance, but many insurers voluntarily pay equivalently for tele-mental health.
Yes, reimbursement rates are moderate compared to some specialties. But telehealth changes the economics:
Example: If you can see 4 patients/hour at $95/visit (Medicare rate for 99213), that’s $380/hour gross — before platform fees but also before any overhead. Compare that to traditional practice where you might see 2-3 patients/hour but pay $5,000+/month in office costs.
Let’s talk about what it actually costs to build a patient panel — because this is where telehealth platforms like Klarity make or break the business case.
Many providers think: ‘I’ll just market myself — SEO, Google Ads, directory listings. How hard can it be?’
Here’s the reality:
SEO (Organic Search):
Google Ads:
Directory Listings (Psychology Today, Zocdoc, etc.):
The All-In Reality:When you factor in ALL costs — agency/consultant fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, months of SEO investment before results, and failed campaigns — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient.
And that’s just to get them in the door once. Building a full patient panel of 50-100 active patients? You’re looking at $10,000-25,000+ in upfront marketing spend, spread over 6-12 months, with uncertain results.
Compare that to Klarity’s approach:
How it works:
What you get:
The Economics:Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI vs gambling on marketing channels that might not work.
Example:
For providers starting out or scaling, a platform that handles patient acquisition removes the risk entirely. You can focus on clinical care, not becoming a marketing expert.
To be clear: DIY marketing can eventually be cost-effective IF:
But for most providers — especially those starting out, scaling their practice, or maximizing telehealth reach — a platform that handles patient acquisition is the smarter economic choice.
Anxiety disorders are among the most common mental health conditions nationwide. Demand for medication management is exploding, particularly in states facing severe psychiatrist shortages.
The numbers:
These shortages, combined with rising anxiety cases post-pandemic, mean telehealth platforms can help you reach underserved areas where local access is terrible.
Multi-state practice: Many providers leverage licensure compacts (like the Interstate Medical Licensure Compact for physicians) or obtain licenses in multiple states to expand their reach. States like Florida offer special telehealth provider registrations for out-of-state clinicians — though remember, those registrations don’t allow controlled substance prescribing without full licensure.
The platform advantage: Joining a telepsychiatry platform offers access to broader patient populations, streamlined reimbursement, and flexible practice within state regulations — without the overhead of traditional practice or the risk of DIY marketing.
Can a nurse practitioner prescribe anxiety medication?Yes, in all 50 states — but the conditions vary. In Full Practice Authority states (like New York, Arizona), PMHNPs can prescribe independently. In restricted states (like Texas, Pennsylvania), you need a collaborative agreement with a physician.
Can I prescribe benzodiazepines via telehealth?Yes, through December 2026 under federal telehealth flexibilities (and likely beyond with new permanent rules). You must comply with state PDMP requirements and conduct appropriate patient evaluations.
What’s the difference between a psychiatrist and PMHNP for anxiety prescribing?Psychiatrists have unrestricted authority in all states. PMHNPs’ authority depends on state law — ranging from full independence to mandatory physician supervision. For routine anxiety care, experienced PMHNPs provide equivalent outcomes to psychiatrists in most cases.
Do I need malpractice insurance for telehealth prescribing?Yes, absolutely. Ensure your policy covers telehealth services and multi-state practice if applicable.
How do I get licensed in multiple states?Physicians can use the Interstate Medical Licensure Compact (IMLC) if your state participates (not California or New York). NPs can use the Nurse Licensure Compact (NLC) for practice (not prescribing — you’ll need individual state prescriptive authority). Some states offer expedited telehealth licenses.
What happens when the DEA’s temporary rules expire in 2026?The DEA is expected to issue permanent regulations by late 2026. These will likely include a special telemedicine prescribing registration and possibly some patient verification requirements. Stay tuned to DEA announcements and professional organization updates.
Whether you’re a psychiatrist or PMHNP, you have real opportunities to treat anxiety via telehealth in 2026 — but success depends on understanding your specific prescribing authority, state regulations, and practice economics.
For Psychiatrists:You have full prescriptive authority nationwide. The main considerations are state licensing, telehealth compliance, and finding a practice model (platform vs solo) that maximizes your income while minimizing admin burden.
For PMHNPs:Know your state’s scope of practice laws inside and out. If you’re in a restricted state, factor collaboration costs and limitations into your career planning. Consider obtaining licenses in Full Practice Authority states to expand your telehealth reach.
For Both:The economics favor platforms that handle patient acquisition, billing, and infrastructure over DIY marketing (unless you have deep pockets and patience). Pay-per-performance models eliminate upfront risk and let you focus on clinical care.
Klarity Health connects psychiatrists and PMHNPs with patients seeking anxiety treatment — without the marketing gamble or administrative headaches.
What you get:
You focus on clinical care. We handle everything else.
Explore joining Klarity’s provider network and start seeing anxiety patients on your schedule — with guaranteed economics and none of the marketing risk.
[Learn more about joining Klarity’s provider network →]
U.S. Department of Health and Human Services. (2026, January 2). HHS & DEA Extend Telemedicine Flexibilities Through 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Florida Senate. (2024). Florida Statutes §464.012 – Certification of Advanced Practice Registered Nurses and §456.47 – Telehealth. https://www.flsenate.gov/laws/statutes/2024/464.012 and https://www.flsenate.gov/laws/statutes/2022/456.47
California Board of Registered Nursing. (2024). AB 890 Implementation – Nurse Practitioner Practice. https://rn.ca.gov/practice/ab890.shtml
Nurse Practitioners of New York. (2022, April 9). Breaking News: NP Modernization Act Passes. https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes
Texas Medical Board. (2026). Who Can Prescribe Schedule II Drugs Under Physician Delegation? https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation
Find the right provider for your needs — select your state to find expert care near you.